ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 648316 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 648316; 2) Community: the network communities that were significantly associated with the response to NSC 648316; 3) Molecule: the relationships between components within communities and NSC 648316; 4) MDR: the compounds that were significantly associated with the NSC 648316.

NSC Compound Enrichment Correlation
NSC 113943 6-Bromosangivamycin 0.0133986477026051 0.048620632
NSC 135962 Aracytidine 5'-palmitate 0.0133986477026051 0.50583958
NSC 164970 Propanedinitrile, [(3,5-dibromo-2-ethoxyphenyl)methylene]- 0.0133986477026051 0.22797782
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0133986477026051 0.53880924
NSC 261726 ICN 4221 0.0133986477026051 0.12706394
NSC 31780 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) 0.0133986477026051 0.084427534
NSC 375162 Imidazo[1,2-a]pyridine-6-carboxaldehyde, 2-[4-[[(4,5-dihydro-1H-imidazol-2-yl)hydrazono]methyl]phenyl]-, (4,5-dihydro-1H-imidazol-2-yl)hydrazone, dihydroiodide 0.0133986477026051 0.34135337
NSC 625603 Null 0.0133986477026051 0.11853088
NSC 629971 Camptothecin Derivative 0.0133986477026051 0.48977254
NSC 641241 2-Naphthalenebutanamide, alpha-,gamma-dioxo-beta-(3-oxo -2-benzoisofuran-1-yl)-N-[3-(trifluoromethyl)phenyl]- 0.0133986477026051 0.43814226
Total:76  Current:27    [First] [Prev] [Next] [Last]